AVECHO BIOTECHNOLOGY LIMITED
ASX
AU Flag
AVE

AVE
AVECHO BIOTECHNOLOGY LIMITED
AU Flag
ASX
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

AVE Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Pharmaceuticals
Employees: 29
Avecho Biotechnology Limited, formerly Phosphagenics Limited, is an Australia-based research-based biotechnology company. The principal activities of the Company are the development, production, sale and licensing of products incorporating its platform technology Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care, and animal health and nutrition industries. The Company's segments include Production and Personal Care, and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers delivery of drugs through gels, injectables and patches. The Human Health segment focuses on development of patches, including TPM/Oxymorphone and TPM/Oxycodone. The Company has various development programs under its animal health and nutrition. The Company has completed multiple studies assessing TPM as a feed additive in pigs and poultry.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out